Chia-wen Chang
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease.
GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease.
Journal: Journal of neurology
Published: December 04, 2023
Optoelectronic Effects of Copper-Indium-Gallium-Sulfur (CIGS2)-Solar Cells Prepared by Three-Stage Co-Evaporation Process Technology.
Journal: Micromachines
Published: July 17, 2023
Rare VPS35 A320V Variant in Taiwanese Parkinson's Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology.
Journal: Brain sciences
Published: September 25, 2020
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.
Journal: Frontiers in neurology
Published: November 21, 2018
Cheiro-Oral syndrome caused by thalamus hemorrhage: A case report.
Journal: Medicine
Published: February 27, 2018
Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: December 22, 2017
Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification.
Journal: International journal of nanomedicine
Published: November 16, 2017
Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: December 30, 2015
Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation.
Journal: Biochemical pharmacology
Published: September 17, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026